Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016)

Guided Therapeutics has disclosed Current Deferred Tax Assets across 5 years of filings, most recently posting $795000.0 for Q4 2016.

• In Q4 2016, Current Deferred Tax Assets rose 27.0% year-over-year to $795000.0; the TTM figure through Dec 2016 stood at $795000.0 (up 27.0% YoY), while the FY2016 annual figure was $795000.0, up 27.0% from the prior year.
• Current Deferred Tax Assets came in at $795000.0 for Q4 2016 at Guided Therapeutics, up from $626000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $795000.0 in Q4 2016 to a low of $277000.0 in Q4 2012.
• Average Current Deferred Tax Assets over 5 years is $490200.0, with a median of $466000.0 recorded in 2014.
• Year-over-year, Current Deferred Tax Assets grew 3.61% in 2013 and surged 62.37% in 2014.
• Over 5 years, Current Deferred Tax Assets stood at $277000.0 in 2012, then advanced by 3.61% to $287000.0 in 2013, then surged by 62.37% to $466000.0 in 2014, then soared by 34.33% to $626000.0 in 2015, then rose by 27.0% to $795000.0 in 2016.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $795000.0 in Q4 2016, $626000.0 in Q4 2015, and $466000.0 in Q4 2014.